Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Oncoimmunology|April 15, 2025
Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancerFabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.Plos One|January 8, 2019
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB)Christos Chouaid, Mathieu Salaün, Valérie Gounant, et al.Oncoimmunology|January 18, 2021
Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS studyFabrice Barlesi, Adrien Dixmier, Didier Debieuvre, et al.Lung Cancer (Amsterdam, Netherlands)|May 13, 2021
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and CanadaDidier Debieuvre, Rosalyn A Juergens, Bernard Asselain, et al.The European Respiratory Journal|March 3, 2022
Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trialFlorian Guisier, Gaëtan Deslee, Philippe Birembaut, et al.Pageof 1